Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Somatostatin Analogs”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004327
What this trial is testing

Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaEctasia
National Center for Research Resources (NCRR) 8
Early research (Phase 1)UnknownNCT03308682
What this trial is testing

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 30
Post-approval studies (Phase 4)Study completedNCT01618513
What this trial is testing

Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target

Who this might be right for
Acromegaly
University of Aarhus 84
Testing effectiveness (Phase 2)Ended earlyNCT00510224
What this trial is testing

Sandostatin for Patients With Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 13
Post-approval studies (Phase 4)Study completedNCT01070758
What this trial is testing

Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy

Who this might be right for
Congenital Hyperinsulinism
Sheba Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT02217800
What this trial is testing

The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics

Who this might be right for
Acromegaly
Aspireo Pharmaceuticals Limited 8
Large-scale testing (Phase 3)Study completedNCT01677910
What this trial is testing

TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 135
Large-scale testing (Phase 3)Study completedNCT02685709
What this trial is testing

Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly

Who this might be right for
Acromegaly
Chiasma, Inc. 146
Not applicableStudy completedNCT01029275
What this trial is testing

Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone

Who this might be right for
Acromegaly
University Hospital, Rouen 89
Testing effectiveness (Phase 2)UnknownNCT03629847
What this trial is testing

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

Who this might be right for
Neuroendocrine Tumors
King Faisal Specialist Hospital & Research Center 30
Not applicableStudy completedNCT01732406
What this trial is testing

Acromegaly Treatment Quality of Life Study

Who this might be right for
Acromegaly
Massachusetts General Hospital 126
Not applicableStudy completedNCT00652379
What this trial is testing

Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients

Who this might be right for
AcromegalyInsulin ResistanceImpaired Glucose Tolerance
University of Aarhus 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT06974344
What this trial is testing

Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)

Who this might be right for
Small-for-Size Syndrome
King Faisal Specialist Hospital & Research Center 80
Large-scale testing (Phase 3)Study completedNCT03000946
What this trial is testing

Prevention of Postoperative Pancreatic Fistula by Somatostatin

Who this might be right for
Pancreatic Surgery
Assistance Publique - Hôpitaux de Paris 655
Not applicableWithdrawnNCT05184231
What this trial is testing

Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

Who this might be right for
Acromegaly
Ipsen
Testing effectiveness (Phase 2)UnknownNCT01203306
What this trial is testing

Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Carcinomas
University of Turin, Italy 42
Large-scale testing (Phase 3)Study completedNCT00690430
What this trial is testing

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Who this might be right for
Symptomatic Refractory Resistant Carcinoid Disease
Novartis Pharmaceuticals 186
Large-scale testing (Phase 3)WithdrawnNCT01860742
What this trial is testing

Randomized Phase III of PRRT Versus Interferon

Who this might be right for
Gastro-intestinal Neuroendocrine Tumors
Jules Bordet Institute
Early research (Phase 1)UnknownNCT02967666
What this trial is testing

Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts

Who this might be right for
Tuberculosis, Pulmonary
National University Hospital, Singapore 30
Post-approval studies (Phase 4)Study completedNCT00642720
What this trial is testing

Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients

Who this might be right for
Quality of LifeAcromegaly
Erasmus Medical Center 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation